Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1063-1081, June 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lukes, R. J.
Right arrow Articles by Butler, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lukes, R. J.
Right arrow Articles by Butler, J. J.

The Pathology and Nomenclature of Hodgkin's Disease

Robert J. Lukes and James J. Butler

Department of Pathology, University of Southern California, School of Medicine, Los Angeles, California (R. J. L.) and Department of Pathology, M. D. Anderson Hospital, Houston, Texas (J. J. B.)

The diverse morphologic expressions of Hodgkin's disease have been reviewed and compared to the numerous histologic terms in the literature and the author's recently proposed histologic types. The relationship of the histologic findings to the clinical stages and survival has also been analyzed. The histologic expressions of the Hodgkin's disease process appear to be separable into the following 6 groups: (a) lymphocytic and/or histiocytic (L & H),1 nodular; (b) lymphocytic and/or histiocytic (L & H), diffuse; (c) nodular sclerosis; (d) mixed; (e) diffuse fibrosis; and (f) reticular. The L & H types represent essentially a predominant lymphocytic proliferation with histiocytes, while diffuse fibrosis and reticular are associated with lymphocytic depletion. Nodular sclerosis has a remarkably high incidence of mediastinal involvement when initially observed, exceeding all other types combined, and appears to represent a regional expression of Hodgkin's disease in the mediastinum. The mixed type appears to reflect a changing disease state. These histologic types, with the exception of nodular sclerosis, represent differences in the frequency of lymphocytes and Reed-Sternberg cells and serve to emphasize their inverse relationship. The histologic findings are regarded as reflections of differences in the state of the host responsiveness and are believed to be related to the recently described immunologic defect. The demonstrated relationship between these histologic types, and the clinical stages and survival, provides further support for the importance of host factors and also presents an effective basis for prognostication. In addition a new histologic type, nodular sclerosis, has emerged as the most important prognostic type when observed in clinical Stage I.

The majority of the terms proposed in the literature for the histologic types of Hodgkin's disease represent designations for the lesion with a predominantly lymphocytic proliferation of either nodular or diffuse type. This lesion is of prognostic significance, but it includes only a small proportion of the prolonged survivors. The classical histologic types of Jackson and Parker are of limited effectiveness in prognosis since the heterogeneous granuloma group includes 80–90% of reported series, contains 79% of the survivors at 15 years in our study, and yet has a relatively short median survival in our comparison study.

1 The groups designated lymphocytic and/or histiocytic will be referred to as "L & H" hereafter with the modification of the nodular or diffuse type.




This article has been cited by other articles:


Home page
RadioGraphicsHome page
P. Toma, C. Granata, A. Rossi, and A. Garaventa
Multimodality Imaging of Hodgkin Disease and Non-Hodgkin Lymphomas in Children
RadioGraphics, September 1, 2007; 27(5): 1335 - 1354.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. F. Dukers, C. J. L. M. Meijer, R. L. ten Berge, W. Vos, G. J. Ossenkoppele, and J. J. Oudejans
High numbers of active caspase 3-positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcome
Blood, June 17, 2002; 100(1): 36 - 42.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.